| David Andrew Sinclair |
David Andrew Sinclair is the founder of Genocea Biosciences, Inc. (founded in 2006), CohBar, Inc. (founded in 2007), Immetas Therapeutics, Inc. (founded in 2018), Tally Health (founded in 2022), Sirtris Pharmaceuticals, Inc. (founded in 2004), and Life Biosciences, Inc. (founded in 2017). Dr. Sinclair is also the founder of Liberty Biosecurity, Inc., Metrobiotech LLC, Arc Bio LLC, and Delavie Sciences LLC. Dr. Sinclair's current job(s) include Vice Chairman at EdenRoc Sciences LLC, Co-Chairman at Frontier Acquisition Corp., Director at American Federation for Aging Research, Director at Segterra, Inc., Director at JumpStart Fertility, Inc., Director at Animal Biosciences, Inc., Director at Iduna Therapeutics, Inc., Director at Galilei Biosciences, Inc., Professor at Harvard Medical School, Venture Partner at Bold Capital Partners, and Venture Partner at Catalio Capital Management LP. Dr. Sinclair's former job(s) include Non-Executive Director at Alterity Therapeutics Ltd. (2019-2022), Venture Partner at Lux Capital Group LLC, and Scientific Advisor at Alpha Wave Global (Venture Capital). Dr. Sinclair's education history includes a graduate degree from Massachusetts Institute of Technology (conferred in 1999) and a doctorate degree from The University of New South Wales. |
| Christian Angermayer |
Christian Angermayer founded Alnylam Europe AG in 2000, ATAI Life Sciences AG in 2018, Presight Capital in 2018, and various other companies. Mr. Angermayer also founded Apeiron Investment Group AG, Samara Asset Group Plc, North American Council For Online Learning Ltd., and various other companies. Mr. Angermayer also currently works at Frontier Acquisition Corp., as Chief Executive & Director, Blackrock Microsystems, Inc., as Director, London School of Hygiene & Tropical Medicine, as Court Member, and various other companies. Mr. Angermayer also formerly worked at Deutsche Maklerservice AG, as Director-Supervisory Board from 2004 to 2007, C-QUADRAT Investment AG, as Director-Supervisory Board from 2006 to 2008, VCH Investment Group AG, as Director-Management Board from 2005 to 2006, and various other companies. Mr. Angermayer received his undergraduate degree from the University of Bayreuth. |
| Peter Attia |
Peter Attia is the founder of Nutrition Science Initiative, which was founded in 2012. He held the title of President at the company. Dr. Attia is also the founder of Zero Longevity Science, Inc. Dr. Attia currently holds the position of Co-Chairman at Frontier Acquisition Corp., Director at PayPal, Inc., and President & Chief Investment Officer at Patriot Global Management LP. Dr. Attia has formerly worked as Director-Business Development & Corporate Strategy at Sapphire Energy, Inc. and as Vice President at McKinsey & Co., Inc.Dr. Attia's education includes a doctorate degree from Stanford University and an undergraduate degree from Queen's University. |
| Scott Carpenter |
Scott Carpenter is currently the Chief Operating Officer & Partner at Alpha Wave Global LLP. He also holds the position of Chief Operating Officer at Pioneer Merger Corp., Pioneer Merger Sponsor LLC, and Frontier Acquisition Corp. Previously, he worked as the Global Head-Operations at CQS Investment Management Ltd. |
| Matthew Corey |
Matthew Corey is currently a Director at EdenRoc Sciences LLC, Life Biosciences, Inc., Immetas Therapeutics, Inc., and Iduna Therapeutics, Inc. He is also the Chief Financial Officer at Alpha Wave Global (Venture Capital), Pioneer Merger Corp., and Frontier Acquisition Corp. Previously, he worked as a Director at Alterity Therapeutics Ltd. and as CFO, Senior Accountant & Controller at Gruss Capital Management LP. He also worked as an Auditor at Rothstein Kass LLP from 2006 to 2009. Corey received his undergraduate degree from Lehigh University and his graduate degree from Seton Hall University School of Law. |
| Jonathan Christodoro |
Jonathan Christodoro is the founder of Patriot Global Management LP, which was founded in 2017. He currently holds the position of President & Chief Investment Officer at Patriot Global Management LP. He is also currently the Chairman of Pioneer Merger Corp., a Director at Herbalife International, Inc., an Independent Director at PayPal Holdings, Inc., an Independent Director at Frontier Acquisition Corp., an Independent Director at Velocity Merger Corp., and a Non-Executive Director at Bolttech Digital Brokerage Singapore Pte Ltd. In the past, Mr. Christodoro has held positions such as Chairman at Enzon Pharmaceuticals, Inc. from 2013 to 2020, Independent Director at Hologic, Inc. from 2013 to 2016, Independent Director at Xerox Corp. from 2016 to 2017, Director at Xerox Corp., Independent Director at Cheniere Energy, Inc. from 2015 to 2017, Director at eBay, Inc. in 2015, Independent Director at Repsol Oil & Gas Canada, Inc. from 2013 to 2015, Independent Director at Herbalife Ltd. from 2013 to 2021, Independent Director at SandRidge Energy, Inc. from 2018 to 2021, Director at Cheniere Energy Partners LP, Managing Director at Icahn Capital LP from 2012 to 2017, Independent Director at American Industrial Transport, Inc. from 2015 to 2017, Director at Lyft, Inc. from 2015 to 2019, Director at Talisman Energy USA, Inc. from 2013 to 2015, and Independent Director at Xerox Holdings Corp. from 2018 to 2021. He also worked as an Investment Professional at P2 Capital Partners LLC. Mr. Christodoro's education includes an undergraduate degree from Cornell University, a graduate degree from Harvard T.H. Chan School of Public Health, and an MBA from The Wharton School of the University of Pennsylvania. |
